HLN
Haleon Plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$9.28
−0.85%Margins
Gross margin
63.3%
EBITDA margin
26.1%
EBIT margin
21.9%
Net margin
14.8%
FCF margin
17.9%
10.0%
Return on equity
5.0%
Return on assets
9.9%
Return on invested capital
0.34x
Asset turnover
$3.1B
Cash from operations
$0.25
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026